Literature DB >> 2482103

Interactions of iloprost and sodium nitroprusside on vascular smooth muscle and platelet aggregation.

P S Lidbury1, E Antunes, G de Nucci, J R Vane.   

Abstract

1. The aim of the study was to assess and quantify any synergism occurring between the stable analogues of prostacyclin (iloprost) and nitric oxide (sodium nitroprusside) with respect to both relaxation of vascular smooth muscle and inhibition of platelet aggregation in the rabbit. 2. Iloprost (0.3-3 ng ml-1) and sodium nitroprusside (0.3-3 ng ml-1) caused dose-dependent relaxation of the rabbit mesenteric and coeliac arteries. 3. Iloprost (0.3-30 ng ml-1) and sodium nitroprusside (0.03-30 micrograms ml-1) caused dose-dependent inhibition of rabbit platelet aggregation induced by adenosine diphosphate or collagen. 4. In combination, iloprost and sodium nitroprusside caused an inhibition of platelet aggregation that was 2-3 fold greater than would be expected by summation, while no such potentiation was observed on vascular smooth muscle. 5. Thus, our results indicate that under physiological conditions the mediators prostacyclin and endothelium-derived relaxing factor (NO) can exert a synergistic action on platelets, but have only an additive effect on vascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2482103      PMCID: PMC1854807          DOI: 10.1111/j.1476-5381.1989.tb12674.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  THE USE OF ISOLATED ORGANS FOR DETECTING ACTIVE SUBSTANCES IN THE CIRCULATING BLOOD.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1964-10

2.  Endothelium-dependent vasodilator-and nitrovasodilator-induced relaxation may be mediated through cyclic GMP formation and cyclic GMP-dependent protein phosphorylation.

Authors:  R M Rapoport; M B Draznin; F Murad
Journal:  Trans Assoc Am Physicians       Date:  1983

3.  Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators.

Authors:  B T Mellion; L J Ignarro; E H Ohlstein; E G Pontecorvo; A L Hyman; P J Kadowitz
Journal:  Blood       Date:  1981-05       Impact factor: 22.113

4.  An improved method for washing of human platelets with prostacyclin.

Authors:  M Radomski; S Moncada
Journal:  Thromb Res       Date:  1983-05-15       Impact factor: 3.944

5.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

Authors:  S Moncada; R Gryglewski; S Bunting; J R Vane
Journal:  Nature       Date:  1976-10-21       Impact factor: 49.962

6.  The interaction of sodium nitroprusside with human endothelial cells and platelets: nitroprusside and prostacyclin synergistically inhibit platelet function.

Authors:  R I Levin; B B Weksler; E A Jaffe
Journal:  Circulation       Date:  1982-12       Impact factor: 29.690

7.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

8.  Modulation of human platelet adenylate cyclase by prostacyclin (PGX).

Authors:  R R Gorman; S Bunting; O V Miller
Journal:  Prostaglandins       Date:  1977-03

9.  Inhibition of platelet function by organic nitrate vasodilators.

Authors:  A I Schafer; R W Alexander; R I Handin
Journal:  Blood       Date:  1980-04       Impact factor: 22.113

10.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

View more
  11 in total

1.  The anti-aggregating effect of BAY 41-2272, a stimulator of soluble guanylyl cyclase, requires the presence of nitric oxide.

Authors:  Séverine Roger; Cécile Badier-Commander; Jérôme Paysant; Alex Cordi; Tony J Verbeuren; Michel Félétou
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

2.  Inhibition of platelet aggregation by transdermal glyceryl trinitrate.

Authors:  R Andrews; J A May; J Vickers; S Heptinstall
Journal:  Br Heart J       Date:  1994-12

3.  Sodium nitroprusside modulates the fibrinolytic system in the rabbit.

Authors:  P S Lidbury; R Korbut; J R Vane
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

4.  The effect of endothelium-derived nitric oxide on ex vivo whole blood platelet aggregation in man.

Authors:  P Vallance; N Benjamin; J Collier
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  Effects of zaprinast and rolipram on platelet aggregation and arrhythmias following myocardial ischaemia and reperfusion in anaesthetized rabbits.

Authors:  M Holbrook; S J Coker
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

6.  Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.

Authors:  E V Negrescu; B Grünberg; M A Kratzer; R Lorenz; W Siess
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

7.  Functional and molecular characterization of endothelium-dependent and endothelium-independent relaxant pathways in uterine artery of non-pregnant buffaloes.

Authors:  Udayraj P Nakade; Abhishek Sharma; Priyambada Kumari; Shirish Bhatiya; Sooraj V Nair; K N Karikaran; Vipin Sharma; Soumen Choudhury; Satish Kumar Garg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-09-07       Impact factor: 3.000

8.  Cyclic nucleotides attenuate thrombin-evoked alterations in parameters of platelet Na/H antiport. The role of cytosolic Ca.

Authors:  M Kimura; N Lasker; A Aviv
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

9.  Effect of prostaglandin E2 and 3-morpholinosydnonimine (SIN-1) on arachidonic acid metabolism in fMLP-stimulated rat neutrophils and on thrombin-induced human platelet aggregation.

Authors:  D Pallapies; K U Jirmann; J Rademann; T Simmet; J Rutowski; A Dembińska-Kieć; B A Peskar
Journal:  Agents Actions       Date:  1992-05

10.  The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects.

Authors:  S L Spinelli; J J O'Brien; S Bancos; G M Lehmann; D L Springer; N Blumberg; C W Francis; M B Taubman; R P Phipps
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.